A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...
Chronic kidney disease (CKD) affects over 800 million people globally and is often diagnosed too late for effective intervention. Early detection depends on accurate measurement of biomarkers such as ...
Is point-of-care (POC) glycated hemoglobin (A1c) testing the best choice for diabetes screening? The option is an attractive one; POC A1c testing provides the convenience of rapid results in a single ...
In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...
Point of care testing in the emergency department: Finding comprehensive solutions that work for you
Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...
Point-of-care testing is disrupting global diagnostics, creating opportunities for companies such as Lumos Diagnostics ...
Binx Health is a health technology company aiming to speed up the time between diagnosis and treatment of sexually transmitted infections with a point-of-care diagnostic solution. The company ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results